Prevalence and significance of naturally occurring mutations in the surface and polymerase genes of hepatitis B virus.

The prevalence and clinical significance of naturally occurring mutations in the full-length surface and overlapping polymerase genes of hepatitis B virus (HBV) were analyzed in 42 patients with chronic hepatitis. Mutations were observed in 10 patients (24%) in the a determinant region, which is the neutralizing epitope within the major hydrophilic region of the surface gene. A high proportion of these mutations (17/18; 94%) occurred in the first loop, unlike mutations induced by immunization. The presence of serum antibody to hepatitis B surface antigen was significantly associated with these mutations. No other region of the surface gene contained any cluster of mutations. These results suggest that escape mutations commonly contribute to persistency in the natural course of HBV infection. In contrast, mutations affecting the major catalytic domains of the polymerase gene, which could alter susceptibility to antiviral nucleoside analogues, were not detected at all.

[1]  J. Roberts,et al.  Incidence and clinical consequences of surface and polymerase gene mutations in liver transplant recipients on hepatitis B immunoglobulin , 1998, Hepatology.

[2]  T. Berg,et al.  Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high‐dose hepatitis B immune globulin after liver transplantation , 1998, Hepatology.

[3]  A. Lok,et al.  Hepatitis B virus S mutants in liver transplant recipients who were reinfected despite hepatitis B immune globulin prophylaxis , 1998, Hepatology.

[4]  S. Wirth,et al.  Detection of different viral strains of hepatitis B virus in chronically infected children after seroconversion from HBsAg to anti-HBs indicating viral persistence. , 1997, Journal of hepatology.

[5]  L. Mimms,et al.  The prevalence of surface antigen variants of hepatitis B virus in Papua New Guinea, South Africa, and Sardinia , 1997, Hepatology.

[6]  H. Hsu,et al.  Surface gene mutants of hepatitis B virus in infants who develop acute or chronic infections despite immunoprophylaxis , 1997, Hepatology.

[7]  C. S. Lee,et al.  Novel and frequent mutations of hepatitis B virus coincide with a major histocompatibility complex class I-restricted T-cell epitope of the surface antigen , 1997, Journal of virology.

[8]  P. Angus,et al.  Hepatitis B virus polymerase mutations during antiviral therapy in a patient following liver transplantation. , 1997, Journal of hepatology.

[9]  S. Günther,et al.  Hepatitis B virus sequence changes evolving in liver transplant recipients with fulminant hepatitis. , 1997, Journal of hepatology.

[10]  D. Samuel,et al.  Evidence for selection of hepatitis B mutants after liver transplantation through peripheral blood mononuclear cell infection. , 1997, Journal of hepatology.

[11]  K. Reddy,et al.  Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation , 1997, The Lancet.

[12]  N. Enomoto,et al.  Sequential changes in full-length genomes of hepatitis B virus accompanying acute exacerbation of chronic hepatitis B. , 1996, Journal of hepatology.

[13]  M. Manns,et al.  Hepatitis B virus envelope variation after transplantation with and without hepatitis B immune globulin prophylaxis , 1996, Hepatology.

[14]  E. Elias,et al.  Selection of mutations in the hepatitis B virus polymerase during therapy of transplant recipients with lamivudine , 1996, Hepatology.

[15]  H. Kohno,et al.  Mutations in the envelope gene of hepatitis B virus variants co-occurring with antibody to surface antigen in sera from patients with chronic hepatitis B. , 1996, The Journal of general virology.

[16]  M. Massari,et al.  Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response. , 1996, The Journal of clinical investigation.

[17]  L. Mimms,et al.  Fulminant reactivation of hepatitis B due to envelope protein mutant that escaped detection by monoclonal HBsAg ELISA , 1995, The Lancet.

[18]  M. Peters Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells , 1995 .

[19]  F. Chisari,et al.  Hepatitis B virus immunopathogenesis. , 1995, Annual review of immunology.

[20]  A. Sette,et al.  Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells , 1994, Nature.

[21]  H. Okamoto,et al.  Naturally occurring escape mutants of hepatitis B virus with various mutations in the S gene in carriers seropositive for antibody to hepatitis B surface antigen , 1994, Journal of virology.

[22]  H. Whittle,et al.  A novel hepatitis B virus variant in the sera of immunized children. , 1994, The Journal of general virology.

[23]  K. Koike,et al.  The serology of chronic hepatitis B infection revisited. , 1993, The Journal of clinical investigation.

[24]  O. Yokosuka,et al.  Mutations in core nucleotide sequence of hepatitis B virus correlate with fulminant and severe hepatitis. , 1993, The Journal of clinical investigation.

[25]  O. Yokosuka,et al.  Precore mutations and core clustering mutations in chronic hepatitis B virus infection. , 1993, Gastroenterology.

[26]  A. Lok,et al.  Natural history and control of perinatally acquired hepatitis B virus infection. , 1992, Digestive diseases.

[27]  O. Yokosuka,et al.  Variations in codons 84-101 in the core nucleotide sequence correlate with hepatocellular injury in chronic hepatitis B virus infection. , 1992, The Journal of clinical investigation.

[28]  R. Zinkernagel,et al.  In vitro selection of lymphocytic choriomeningitis virus escape mutants by cytotoxic T lymphocytes. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[29]  T. Ishikawa,et al.  Detection of pre-C and core region mutants of hepatitis B virus in chronic hepatitis B virus carriers. , 1991, The Journal of clinical investigation.

[30]  Rolf M. Zinkernagel,et al.  Viral escape by selection of cytotoxic T cell-resistant virus variants in vivo , 1990, Nature.

[31]  A. Zuckerman,et al.  Vaccine-induced escape mutant of hepatitis B virus , 1990, The Lancet.

[32]  I Sauvaget,et al.  Identification of four conserved motifs among the RNA‐dependent polymerase encoding elements. , 1989, The EMBO journal.

[33]  R. Miller,et al.  Rapid and sensitive method for the detection of serum hepatitis B virus DNA using the polymerase chain reaction technique , 1989, Journal of clinical microbiology.

[34]  S. Kwok,et al.  Avoiding false positives with PCR , 1989, Nature.

[35]  H. Sakugawa,et al.  Typing hepatitis B virus by homology in nucleotide sequence: comparison of surface antigen subtypes. , 1988, The Journal of general virology.

[36]  H. Okamoto,et al.  Genomic heterogeneity of hepatitis B virus in a 54-year-old woman who contracted the infection through materno-fetal transmission. , 1987, The Japanese journal of experimental medicine.

[37]  H. Okamoto,et al.  Nucleotide sequence of a cloned hepatitis B virus genome, subtype ayr: comparison with genomes of the other three subtypes. , 1986, The Journal of general virology.

[38]  A. Dejean,et al.  The hepatitis B virus , 1985, Nature.

[39]  K. Koike,et al.  Complete nucleotide sequence of hepatitis B virus DNA of subtype adr and its conserved gene organization. , 1984, Gene.

[40]  Asao Fujiyama,et al.  Cloning and structural analyses of hepatitis B virus DNAs, subtype adr , 1983, Nucleic Acids Res..

[41]  Y. Ono,et al.  Tbe complete nudeotide sequences of the cloned hepatitis B vims DNA; subtype adr and adw , 1983 .